BIMI Stock Overview
Engages in the retail and wholesale distribution of medical devices, and pharmaceutical and other healthcare products in the People’s Republic of China. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
BIMI Holdings Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.0075 |
| 52 Week High | US$4.13 |
| 52 Week Low | US$0.001 |
| Beta | 1.16 |
| 11 Month Change | -62.50% |
| 3 Month Change | -62.50% |
| 1 Year Change | -99.62% |
| 33 Year Change | -99.98% |
| 5 Year Change | -100.00% |
| Change since IPO | -100.00% |
Recent News & Updates
Recent updates
With A 60% Price Drop For BIMI Holdings Inc. (NASDAQ:BIMI) You'll Still Get What You Pay For
Apr 03
After Leaping 39% BIMI Holdings Inc. (NASDAQ:BIMI) Shares Are Not Flying Under The Radar
Feb 15Does BIMI International Medical (NASDAQ:BIMI) Have A Healthy Balance Sheet?
Aug 16BIMI International Medical to acquire healthcare products distributor Phenix Bio
Jul 07BOQI International Medical to acquire Chaohu Zhongshan Minimally Invasive Hospital for ~$18.35M
Dec 16BOQI International to acquire Chongqing Guoyitang Hospital for ~$15.24M
Dec 09BOQI International Medical rallies on Chaohu Hospital acquisition
Nov 30BOQI International Medical reports Q3 results
Nov 16BOQI International Medical inks MOU with Chongqing Cogmer Biology Technology
Nov 09Shareholder Returns
| BIMI | US Healthcare | US Market | |
|---|---|---|---|
| 7D | -11.8% | 2.3% | 1.0% |
| 1Y | -99.6% | 5.0% | 31.4% |
Return vs Industry: BIMI underperformed the US Healthcare industry which returned 4.6% over the past year.
Return vs Market: BIMI underperformed the US Market which returned 30.7% over the past year.
Price Volatility
| BIMI volatility | |
|---|---|
| BIMI Average Weekly Movement | 189.8% |
| Healthcare Industry Average Movement | 7.0% |
| Market Average Movement | 6.3% |
| 10% most volatile stocks in US Market | 16.3% |
| 10% least volatile stocks in US Market | 3.1% |
Stable Share Price: BIMI's share price has been volatile over the past 3 months compared to the US market.
Volatility Over Time: BIMI's weekly volatility has increased from 91% to 190% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2000 | 296 | Tiewei Song | usbimi.com |
BIMI Holdings Inc., together with its subsidiaries, engages in the retail and wholesale distribution of medical devices, and pharmaceutical and other healthcare products in the People’s Republic of China. The company operates in four segments: Wholesale Pharmaceuticals, Wholesale Medical Devices, Medical Services, and Retail Pharmacies. It distributes Stryker spinal products, Olympus endoscopes, imported imaging products, and diagnostic imaging equipment to drug stores, private clinics, pharmaceutical dealers, and hospitals in the Southwest region of the People’s Republic of China.
BIMI Holdings Inc. Fundamentals Summary
| BIMI fundamental statistics | |
|---|---|
| Market cap | US$104.71k |
| Earnings (TTM) | -US$10.52m |
| Revenue (TTM) | US$12.63m |
0.0x
P/S Ratio0.0x
P/E RatioIs BIMI overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| BIMI income statement (TTM) | |
|---|---|
| Revenue | US$12.63m |
| Cost of Revenue | US$7.54m |
| Gross Profit | US$5.09m |
| Other Expenses | US$15.61m |
| Earnings | -US$10.52m |
Last Reported Earnings
Sep 30, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.75 |
| Gross Margin | 40.30% |
| Net Profit Margin | -83.27% |
| Debt/Equity Ratio | 18.0% |
How did BIMI perform over the long term?
See historical performance and comparison